Key Dates

Related Announcements

• June 9, 2022 - Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional). See PAR-22-181.

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate in PAR-22-181  "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"  effective for the May 6, 2024 due date and subsequent due dates. The following changes and updates have been made to  PAR-22-181 (shown in bold italics) to reflect NIAMS' participation in this NOFO.

Part 1. Overview Information

Components of Participating Organizations

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute on Drug Abuse (NIDA)

National Institute of Nursing Research (NINR)

National Institute on Minority Health and Health Disparities (NIMHD)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Dietary Supplements (ODS)

Sexual and Gender Minority Research Office (SGMRO)

Office of Research on Women's Health (ORWH)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

 93.307, 93.361, 93.213, 93.121, 93.273, 93.313, 93.837, 93.838, 93.839, 93.840, 93.233, 93.399, 93.279, 93.846

Part 2. Full Text of Announcement, Section I. Notice of Funding Opportunity Description

Areas of Research Interest:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIAMS will support applications that address research into the causes, treatments, and prevention of arthritis and musculoskeletal and skin diseases. The NIAMS Strategic Plan Fiscal Years 2020-2024 provides a broad outline of opportunities and needs related to the understanding, diagnosis, treatment, and ultimately, prevention of diseases within the Institute's mission areas. The Institutes core mission areas are (1) Systemic Rheumatic and Autoimmune Diseases; (2) Skin Biology and Diseases; (3) Bone Biology and Diseases; (4) Muscle Biology and Diseases; and (5) Joint Biology, Diseases, and Orthopaedics. Within these mission areas, NIAMS supports research at multiple levels, ranging from basic studies of the molecular mechanisms underlying disease processes, to preclinical research in model systems, to translational studies, and finally to clinical and epidemiological research. 

In keeping with the 2020-2024 strategic plan's priority area "Management, Scientific Stewardship, and Accountability" NIAMS seeks to continue its commitment to building and maintaining the scientific workforce. Attracting and maintaining a robust, diverse scientific workforce is critical to the NIAMS mission. Many forms of arthritis, musculoskeletal, and skin diseases disproportionately affect Americans from minority racial or ethnic backgrounds and fostering research leaders that reflect that diversity will help improve health equity across NIAMS disease areas. In addition, NIAMS has a long history of supporting New Investigators (NI) and Early-Stage Investigators (ESI) and seek to support investigators in this critical early point in their careers. 

 NIAMS will only support applications that fall within one of NIAMS supported scientific programs. Supported areas can be found here: https://www.niams.nih.gov/grants-funding/funding-opportunities/supported-scientific-areas. Clinical trial applications will be considered low priority for funding through this NOFO. 

It is recommended that investigators contact NIAMS Scientific/Research staff well in advance of submitting applications to discuss the match to NIAMS priorities.

Scientific/Research Contact(s)

Isaah Vincent, PhD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-5507390
Email:  [email protected]

Financial/Grants Management Contact(s)

Erik Edgerton
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Tel:  (301) 594-7760
Email:  [email protected] 

 All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to: